Bailey M. Pendergraft

Bailey Pendergraft practices at Huguley Surgery Center, LLP in Burleson, Texas.

Bailey Pendergraft's NPI, 1376251470, was assigned on November 8, 2022. Bailey Pendergraft holds Texas license PA16509.

Bailey Pendergraft's primary practice is Huguley Surgery Center, LLP, at 12001 S Fwy, Burleson, TX 76028 in Johnson County. The practice phone is (817) 615-4400.

Bailey Pendergraft's primary practice is Huguley Surgery Center, LLP in Burleson, Texas. The medical group on file is Dermatology Southwest. Dmand AI also links Bailey Pendergraft to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Bailey Pendergraft practices. Vendor and product names are available with a free account.

Physician assistant is Bailey Pendergraft's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Bailey Pendergraft is licensed in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, scalp rash, skin cyst and skin discoloration among the conditions Bailey Pendergraft treats.

CMS data shows 2,619 Medicare services from Bailey Pendergraft across 9 procedure codes in 2024, for 492 Medicare patients. Medicare paid $78,865 for them. Every service was in an office.

CMS counts 492 Medicare patients who saw Bailey Pendergraft in 2024. The largest group is 65 to 74, with 211 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Bailey Pendergraft's median patient age at 74, with 51% women.

In 2024, Bailey Pendergraft wrote 715 Medicare Part D claims for 330 patients. 94% of them were for generic drugs. CMS names the drug for 608 of them, across 19 drugs with 11 or more claims each, at $14,781 in total drug cost.

Bailey Pendergraft accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 207 general payments to Bailey Pendergraft from 23 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 98% of the total. Sanofi and Genzyme US Companies paid the most, $765.